CryoIQ

What CryoIQ does

CryoIQ global AB is a Swedish privately held medical device company founded in 1984 that designs, manufactures, and distributes portable cryosurgical devices for the non-invasive treatment of benign skin lesions. Operating from its own factory in Onsala, Halland, Sweden, the company sells three product families — the versatile CryoIQ PRO with interchangeable applicators, the entry-level CryoIQ DERM Plus with fixed tips, and the CryoIQ PRO Aesthetic developed exclusively for the beauty market — each available in liquid spray freezing (−89°C) and contact freezing (−80°C) variants. The devices use medical-grade nitrous oxide (N₂O) in 25-gram disposable cartridges with a patented built-in non-return valve, are CE marked under Medical Device Directive 93/42/EEC Class IIa, and are differentiated from liquid-nitrogen-based alternatives by a limited 4mm penetration depth that reduces scarring risk.

The company monetizes through three revenue streams: one-time hardware sales of devices, recurring consumable revenue from replacement N₂O cartridges (sold in packs of 1, 4, or 10 with approximately three-year shelf life and ~540 seconds of freezing time per cartridge), and replacement applicator tips and accessories (standard, dermatology, angled, long, and gynecology tips in various sizes) plus an extendable warranty from one to two years. CryoIQ sells exclusively through a global network of authorized distributors serving licensed practitioners across at least eight segments: general practice, veterinary medicine, aesthetic medicine, podiatry, pediatrics, gynecology/urology, dermatology, and ophthalmology. The company maintains separate regional websites for the UK and US markets, operates the CryoIQ Academy educational platform for practitioner training and certification, and is led by President Stefan Skafte. The ownership structure is founder-led with no disclosed external institutional investment, venture capital backing, or parent holding company.

Name

CryoIQ

Legal name

CryoIQ global AB

Website

https://cryoiq.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

1–10 employees

Short description

CryoIQ is a privately held Swedish medical device company founded in 1984 that designs and manufactures portable nitrous-oxide-based cryosurgical devices for treating benign skin lesions, selling exclusively through a global authorized distributor network to licensed medical, veterinary, dermatology, and aesthetic practitioners.

Ownership category

akta.pro rank

Headquarters

HQ city

Halmstad

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Cryosurgical Device Sales: Sale of cryosurgical hardware devices including PRO, DERM Plus, and PRO Aesthetic product lines. Devices are sold with plastic storage cases and include 25-gram gas cartridges.
2. Disposable N2O Gas Cartridges: Recurring consumable revenue from 25-gram nitrous oxide gas cartridges. Cartridges available in packages of 1, 4, or 10 units. Shelf life of approximately 3 years from production date.
3. Applicator Tips and Accessories: Replacement and additional applicator tips (contact, spray, angled, gynecology) and accessories including protective caps, freeze limiters, and ruler tools.
4. Extended Warranty: Standard 1-year warranty extendable to 2 years upon product registration, providing extended coverage revenue opportunity.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

CryoIQ manufactures portable cryosurgical devices using medical-grade nitrous oxide for non-invasive treatment of benign skin lesions across medical, veterinary, and aesthetic applications. The portfolio includes three device families—PRO, DERM Plus, and PRO Aesthetic—each offered in Liquid spray and Contact variants, alongside recurring 25-gram nitrous oxide gas cartridges. Products are developed and produced in-house at the company's own factory in Sweden and sold globally through authorized distributors.

Product overview

CryoIQ offers a portfolio of cryosurgical medical devices for non-invasive treatment of benign skin lesions using extreme cold. The product line consists of three main device families: PRO (best-selling, most versatile with interchangeable applicators for medical and veterinary use), DERM Plus (baseline/new generation model with fixed applicators for smaller practices), and PRO Aesthetic (beauty market-exclusive with comprehensive applicator options). Each family offers both Liquid (spray freezing) and Contact (direct tip application) variants. The devices use medical-grade nitrous oxide (N₂O) as cryogen, delivering temperatures of -80°C to -89°C through various interchangeable or fixed applicator tips ranging from 1mm to 28mm. Products are developed and manufactured in Sweden with CE marking under Medical Device Directive 93/42/EEC Class IIa. Accessories include applicator tips (standard, dermatology, angled, long, gynecology), 25g gas cartridges, plastic carrying cases, freeze limiters, and protective caps.

Differentiator

Problem solved

Functional benefit

Brands

• CryoIQ PRO: Best-selling, most versatile cryosurgical device for medical and veterinary practices with interchangeable applicators for dermatology, podiatry, gynecology/urology, and veterinary applications.
• CryoIQ DERM Plus
• CryoIQ PRO Aesthetic
• CryoIQ Academy

Products and services

• CryoIQ PRO Liquid Most popular spray freezing device for treating benign, non-cancerous skin lesions. Features six interchangeable applicator tips including standard, dermatology (60/80/100μm), angled (45°), long, and gynecology tips, with freezing temperature of -89°C/-128°F and 725 psi freezing effect. Designed for licensed medical, veterinary, and aesthetic practitioners.
• CryoIQ PRO Contact Versatile contact freezing device with interchangeable contact tips in 1, 3, 5, and 7mm sizes, designed for removing circular and symmetric skin lesions such as lentigo and beauty spots. Freezes at -80°C/-112°F with gold plated metal construction. Targeted at dermatology, podiatry, gynecology/urology, and veterinary practices.
• CryoIQ DERM Plus Liquid Easiest-to-use device for treating warts and common benign skin lesions. Features built-in non-return valve preventing gas leakage and maximizing gas use, with freezing temperature of -89°C and fixed standard applicator for liquid spray freezing. Suitable for general practice, dermatology, pediatrics, podiatry, aesthetics, veterinary, gynecology, and urology.
• CryoIQ DERM Plus Contact Baseline model with fixed 1, 3, or 5mm contact tips for treating small circular and symmetric skin lesions. Freezing temperature of -80°C/-112°F with 3mm penetration depth. Features built-in non-return valve preventing gas leakage. Targeted at general practice, dermatology, pediatrics, podiatry, aesthetics, and veterinary applications.
• CryoIQ PRO Aesthetic Liquid Spray freezing device for aestheticians and beauticians to remove beauty spots, lentigo, and benign skin lesions. Features seven interchangeable applicator tips including standard (60μm), dermatology (60/80/100μm), angled (45°), long (100μm), and gynecology (100μm) tips, with freezing temperature of -89°C/-128°F. Designed for licensed beauty and aesthetic market practitioners.
• CryoIQ PRO Aesthetic Contact Contact freezing device for removing circular, symmetric skin lesions such as lentigo and beauty spots. Features four interchangeable applicator tips (1, 3, 5, and 7mm), freezing temperature of -80°C/-112°F, stainless steel construction, and ergonomic pencil-type grip. Targeted at licensed aestheticians and beauticians.
• CryoIQ N2O Gas Cartridges (25g) Medical grade 25-gram nitrous oxide (N2O) gas cartridges with built-in non-return valve, available in packages of 1, 4, or 10. Shelf life of approximately three years from production date, providing approximately 540 seconds of freezing time with the standard applicator. Recurring consumable for CryoIQ device users.

Quantifiable outcome

• Treatment duration of 20 seconds or less for most skin lesions
• +4 more outcomes

Segments8 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Authorized Distributor NetworkcoreChannel Partner/ Reseller/ DistributorCryoIQ distributes its products exclusively through a network of authorized distributors covering global markets. Distributors serve various segments including medical practice, veterinary, aesthetic, podiatry, dental, gynecology, beauty, and LipoCryoLysis markets. The company actively recruits new distributors through its 'Become a distributor' program.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• CooperSurgical: Large women's health and medical device company with products spanning gynecology, dermatology, and fertility. Overlaps with CryoIQ in gynecology/urology cryosurgery applications but operates as a diversified portfolio player rather than a cryo-specialist.
• Apyx Medical (formerly Bovie Medical): Public medical device company offering electrosurgical and aesthetic products, including cryotherapy-adjacent offerings. Larger incumbent operating across multiple specialties rather than specializing in cryosurgery specifically.

Direct peers

• H&O Equipments (Cryo-S Electronic): Belgian manufacturer of cryosurgery devices (Cryo-S) for medical and veterinary use. Comparable niche player with handheld cryosurgical devices targeting dermatology, general practice, and veterinary clinicians, similar to CryoIQ's portfolio.
• Brymill Cryogenic Systems: Leading manufacturer of cryosurgery devices primarily using liquid nitrogen for dermatology and medical practices. Closest direct competitor to CryoIQ in the portable cryosurgery device category, but differentiated by cryogen (LN2 vs. CryoIQ's N2O) and CryoIQ's built-in valve cartridge system.
• Wallach Surgical Devices: Established manufacturer of cryosurgical instruments for medical, dermatology, and veterinary applications. Competes with CryoIQ across overlapping end-user specialties but uses traditional liquid nitrogen delivery; comparable product scope but different cryogen architecture.
• CryoPen: Manufacturer of portable cryosurgery pens for skin-lesion treatment in medical and aesthetic practices. Highly comparable to CryoIQ in product form factor (portable handheld cryosurgery device) and end-customer base (clinicians treating benign lesions).

Emerging players

• MedGyn Products: Specialty medical device company focused on women's health, obstetrics/gynecology, and related clinical applications. Comparable to CryoIQ's gynecology/urology cryosurgery line but with a broader reproductive-health product portfolio.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/cryoiq
• LinkedInlinkedin.com/company/cryoiq-ab
• Instagraminstagram.com/cryoiq
• Xx.com/cryoiq

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CryoIQ